Feedback / Questions
namodenoson (CF102) - Can-Fite
https://www.globenewswire.com/news-release/2026/01/20/3221562/0/en/Can-Fite-Completes-Patient-Enrollment-in-Phase-2a-Pancreatic-Cancer-Study-of-Namodenoson.html
Jan 20, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next